To investigate the relationship between changes in plasma deoxynucleoside concentrations and response and toxicity in patients treated with capecitabine.
Department of Pharmacology, Faculty of Medicine, Institute of Biomedical Research, School of Medical Sciences, University of Sydney, Sydney, NSW, Australia.